Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks…
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of…
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
GBT
Tag: GBT
Global Blood Therapeutics Inc. (NASDAQ: GBT) Receives Marketing Approval From the...
Kate Hudson
-
February 28, 2022
0
Global Blood Therapeutics (NASDAQ: GBT) Receives Favorable Scientific Opinion From UK...
Gavins Felicity
-
February 10, 2022
0
Global Blood Therapeutics Inc. (NASDAQ: GBT) Announces Phase 1 GBT601 Study...
Gavins Felicity
-
December 24, 2021
0
Global Blood Therapeutics Inc. (NASDAQ: GBT) Presents GBT601 Study and Oxbryta...
Kate Hudson
-
December 23, 2021
0
Recent Post
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
admin
-
April 1, 2024
0
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapy treatments, is at...
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks...
March 29, 2024
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
March 26, 2024
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
March 25, 2024
Pharmaceutical Giants Navigate Market Tides: A Glimpse into the Future of...
March 25, 2024